AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 68 filers reported holding AMICUS THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $38,000 | +22.6% | 3,951 | 0.0% | 0.00% | – |
| Q3 2019 | $31,000 | -36.7% | 3,951 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $49,000 | +6.5% | 3,951 | +23.5% | 0.00% | – |
| Q4 2017 | $46,000 | -82.4% | 3,200 | -81.6% | 0.00% | -100.0% |
| Q3 2017 | $261,000 | -10.6% | 17,400 | -40.2% | 0.00% | -50.0% |
| Q2 2017 | $292,000 | +133.6% | 29,100 | +65.3% | 0.00% | +100.0% |
| Q1 2017 | $125,000 | +45.3% | 17,600 | -52.4% | 0.00% | 0.0% |
| Q4 2013 | $86,000 | – | 37,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |